|
Emerging Therapies in Respiratory Disease
11th
September 2007 |
|
The classes of drugs licensed to treat
respiratory diseases has not dramatically changed over the last 25 years.
Nevertheless, as unmet medical need is still high, this disease area is
still the subject of intense research effort by the pharmaceutical
industry and academia. Inhalation as a delivery route offers unique
advantages, with more recent advances including the potential for once
daily dosing. This meeting will review current thinking in the area of airway drug delivery and the challenges and progress made in the discovery and development of novel medicines to treat respiratory diseases, such as chronic obstruction pulmonary disease (COPD), asthma, allergic rhinitis and cystic fibrosis. |
| What would you like to do? |
|
| Please contact the SMR Secretariat if you have any further queries. |
| Home / Meetings / Membership / Student Bursaries / Administration / History of the SMR / SMR Award / Archive Material / Links / Contact Us |